This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

This study is currently recruiting participants.
See Contacts and Locations
Verified April 2017 by Donald Arnold, McMaster University
Sponsor:
Collaborators:
GlaxoSmithKline
Hamilton Health Sciences Corporation
Novartis
Information provided by (Responsible Party):
Donald Arnold, McMaster University
ClinicalTrials.gov Identifier:
NCT01621204
First received: June 12, 2012
Last updated: April 6, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)